Hindsight is 20/20 When it Comes to Prosecuting Purdue
Prosecutor admits he didn’t want to take OxyContin off the market.
Prosecutor admits he didn’t want to take OxyContin off the market.
Anxiety treatment FDA never approved is being abused in the U.S.
Senator calls for more funding as Hawaii’s meth problem surpasses its opioid issue.
ISO, a synthetic opioid from China, claims the lives of 19 U.S. residents.
Drug distributor Mallinckrodt paid out bonuses to key players amid bankruptcy talks.
Teva allegedly withheld pertinent evidence prior to reaching opioid settlement.
Advocates suggest B.C. institute Dr. Henry’s proposed reforms to curtail escalating overdose rate.
Parties shift blame to physicians, users in California opioid litigation.
Patients overprescribed opioids post-knee surgery are at higher risk of overdosing.
Catalyst tries to mitigate approval of Jacobus’ LEMS treatment drug.